Skip to main content
High RiskFDAfda-F-1779-2024CHEMICAL EXPOSURE

Scortisoara macinata/ Ground cinnamon, 15 g, Paper cartons, 20 pieces per paper carton

Category
Units Affected
30
Recall Date
July 29, 2024
Issuing Agency
Hazard
Chemical Exposure

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1779-2024.

MAMTAKIM Inc.,888 Magnolia Ave, Elizabeth NJ 07201 is initiating a recall of Scortisoara macinata/ Ground cinnamon, 15 g, Paper cartons, 20 pieces per paper carton, Code: 10C035 because the ground cinnamon product contain elevated levels of lead .

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1779-2024.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Mamtakim, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1779-2024.

MAMTAKIM, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Mamtakim, Inc. Recall FAQ

Mamtakim, Inc. is the subject of a food safety report: Scortisoara macinata/ Ground cinnamon, 15 g, Paper cartons, 20 pieces per paper carton. The notice was published on July 29, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 30 units are potentially affected.